Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.05
-0.95 (-2.79%)
Apr 3, 2025, 4:08 PM HKT

Shanghai Henlius Biotech Revenue

In the year 2024, Shanghai Henlius Biotech had annual revenue of 5.72B CNY with 6.11% growth. Shanghai Henlius Biotech had revenue of 2.98B in the half year ending December 31, 2024, with 54.69% growth.

Revenue
5.72B CNY
Revenue Growth
+6.11%
P/S Ratio
2.95
Revenue / Employee
1.63M CNY
Employees
3,515
Market Cap
17.96B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.72B329.54M6.11%
Dec 31, 20235.39B2.18B67.82%
Dec 31, 20223.21B1.53B91.07%
Dec 31, 20211.68B1.09B186.34%
Dec 31, 2020587.59M496.66M546.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition